搜索页_+Bicalutamide

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

外文资源

Elsevier电子期刊(308)

在“Elsevier电子期刊”中，命中：308条，耗时：小于0.01 秒

在所有数据库中总计命中：308条

1.Bioflavonoid hesperetin overcome bicalutamide induced toxicity by co-delivery in novel SNEDDS formulations: Optimization, in vivo evaluation and uptake mechanism

作者：Abhishek Arya^a ; ^b ; ^{abhishekarya55@gmail.com} ; Hafsa Ahmad^a ; Sachin Tulsankar^b ; ^c ; Satish Agrawal^a ; ^b ; Naresh Mittapelly^a ; ^b ; Rajkumar Boda^a ; Rabi S. Bhatta^c ; Kalyan Mitra^d ; Anil K. Dwivedi^a ; ^{anilcdri@gmail.com}

关键词：Bicalutamide ; Hesperetin ; Antioxidant ; Reactive oxygen species ; Toxicity ; Prostate cancer

刊名：Materials Science and Engineering: C

出版年：2017

2.Re: Efficacy and Safety of Enzalutamide versus Bicalutamide for Patients with Metastatic Prostate Cancer (TERRAIN): A Randomised, Double-Blind, Phase 2 Study

作者：Samir S. Taneja ; MD

刊名：The Journal of Urology

出版年：2017

3.Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer

作者：Marc Gaudet^a ; ^b ; ^{marcgaudet@ssss.gouv.qc.ca" class="auth_mail" title="E-mail the corresponding author} ; É ; ric Vigneault^a ; ^c ; William Foster^a ; Franç ; ois Meyer^c ; André ; -Guy Martin^a ; ^c

关键词：Prostate ; Cytoreduction ; Brachytherapy ; Dutasteride ; Bicalutamide

刊名：Radiotherapy and Oncology

出版年：2016

4.The fluorescent two-hybrid assay for live-cell profiling of androgen receptor modulators

作者：Jacqueline Bogner^a ; Kourosh Zolghadr^a ; Ian Hickson^b ; Tina Romer^a ; ^{t.romer@chromotek.com} ; Larisa Yurlova^a

关键词：AR ; androgen receptor protein ; BHK ; baby hamster kidney ; CMV IE ; immediate early promoter of cytomegalovirus ; CRPC ; castration resistant prostate cancer ; CYP17 ; 17α-hydroxy/17 ; 20-lyase ; DAPI ; 4&prime ; 6-diamidino-2-phenylindole ; DBD ; DNA-binding domain ; DHT ; 5α-dihydrotestosterone ; DMEM ; Dulbecco&rsquo ; s Modified Eagle Medium ; DNA ; deoxyribonucleic acid ; F2H ; fluorescent two-hybrid ; FDA ; Food and Drug Administration ; GFP ; green fluorescent protein ; HCA ; high-content analysis ; HEK ; human embryoni

刊名：The Journal of Steroid Biochemistry and Molecular Biology

出版年：2017

5.Design and synthesis of indoline thiohydantoin derivatives based on enzalutamide as antiproliferative agents against prostate cancer

作者：Minzan Zuo¹ ; Xi Xu¹ ; Zhouling Xie ; Raoling Ge ; Ziyu Zhang ; Zhiyu Li ; ^{zhiyuli@cpu.edu.cn} ; Jinlei Bian

关键词：Prostate cancer ; Androgen receptor ; Antagonist ; Indoline thiohydantoin derivatives

刊名：European Journal of Medicinal Chemistry

出版年：2017

6.Re: Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial

刊名：European Urology

出版年：2017

7.Analytical and semipreparative high performance liquid chromatography enantioseparation of bicalutamide and its chiral impurities on an immobilized polysaccharide-based chiral stationary phase

作者：Daniele Sadutto^a ; Rosella Ferretti^a ; Leo Zanitti^a ; Adriano Casulli^b ; Roberto Cirilli^a ; ^{rcirilli@iss.it" class="auth_mail" title="E-mail the corresponding author}

关键词：Enantiomers ; Chiralpak IA ; Bicalutamide ; Impurities ; Temperature-variable HPLC ; Semipreparative resolution

刊名：Journal of Chromatography A

出版年：2016

8.Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer

作者：Marcella Bassetto¹ ; Salvatore Ferla ; ¹ ; ^{Ferlas1@cardiff.ac.uk" class="auth_mail" title="E-mail the corresponding author} ; Fabrizio Pertusati¹ ; Sahar Kandil ; Andrew D. Westwell ; Andrea Brancale ; Christopher McGuigan

关键词：Bicalutamide ; Enzalutamide ; Prostate cancer ; Perfluoroalkyl ; Androgen receptor ; Antiproliferative activity

刊名：European Journal of Medicinal Chemistry

出版年：2016

9.Efficacy and safety of enzalutamide versus bicalutamide for patients with metastatic prostate cancer (TERRAIN): a randomised, double-blind, phase 2 study

作者：Dr Neal D Shore ; MD^a ; ^{nshore@gsuro.com" class="auth_mail" title="E-mail the corresponding author} ; Simon Chowdhury ; MD^b ; Prof Arnauld Villers ; MD^c ; Laurence Klotz ; MD^d ; Prof D Robert Siemens ; MD^e ; De Phung ; BSc^f ; Steve van Os ; MD^f ; Nahla Hasabou ; MD^g ; Fong Wang ; MD^h ; Suman Bhattacharya ; PhD^h ; Prof Axel Heidenreich ; MDⁱ

刊名：The Lancet Oncology

出版年：2016

10.Targeting the androgen receptor in triple-negative breast cancer

作者：Ayca Gucalp ; MD^a ; ^b ; Tiffany A. Traina ; MD^a ; ^b ; ^{trainat@mskcc.org}

关键词：Triple negative breast cancer ; Androgen receptor ; Bicalutamide ; Enzalutamide ; Abiraterone acetate ; Seviteronel

刊名：Current Problems in Cancer

出版年：2016

按检索点细分(308)

题名(152)

关键词(68)

文摘(225)

按出版年细分(308)

2027年及以后(7)

2017年(5)

2016年(21)

2015年(4)

2013年(8)

2012年(22)

2011年(9)

2010年(17)

2009年(10)

2008年(28)

2007年(23)

2006年(21)

2005年(21)

2004年(12)

2003年(18)

2002年(26)

2001年(12)

2000年(3)

2000年及以前(41)